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Available online 16 March 2017Rabbit Embryonic Fibroblast (RbEF) cells (from Hycole hybrid rabbit foetus) were reprogrammed by lentiviral
delivery of a self-silencing hOKSMpolycistronic vector. The pluripotency of the newly generated RbiPSCwas ver-
iﬁed by the expression of pluripotency-associated markers and by in vitro spontaneous differentiation towards
the 3 germ layers. Furthermore, the spontaneous differentiation potential of the iPSC was also tested in vivo by
teratoma assay. The iPSC line showed normal karyotype. The advantages of using RbiPSC are the easy access to
primary material and the possibility to study the efﬁcacy and safety of the iPSC-based therapies on a non-rodent
animal model.
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RbEF was isolated from day 12 foetuses andmaintained under stan-
dard conditions. The RbEFs were reprogrammed with lenti-viral deliv-
ery using the pRRL.PPT.SF.hOKSMco.idTomato.preFRT (Voelkel et al.,
2010; Warlich et al., 2011) polycistronic vector, containing human
reprogramming factors (OCT4, SOX2, C-MYC, and KLF4), driven by
SFFV retroviral promoter. The construct was introduced into RbEF cells
by transduction. The newly generated rabbit iPSCs closely resembled
to that of the human iPSC's morphology and culture requirements:
they formed ﬂattened colonies and proliferated indeﬁnitely in the pres-
ence of bFGF. RbiPSC-like colonies were picked 18–21 days post-trans-
duction. Stable lines were maintained and based on morphology
criteria were chosen for further examination. Themycoplasma-free sta-
tus of the cell line was conﬁrmed regularly by the Venor GeM Advance
detection kit (Minerva Biolabs, Berlin, Germany).
The pluripotency of the RbiPSC line was examined by immunocyto-
chemistry staining, using antibodies against human OCT4, SOX2, and
SSEA4 (Fig. 1A). The in vitro spontaneous differentiation potential to-
wards the three germ layer of RbiPSC line was demonstrated by the ex-
pression of ectodermal (βIII-TUBULIN),mesodermal (SMOOTHMUSCLE
ACTIN) and endodermal (GATA4) markers (Fig. 1A). Moreover, RbiPSC
formed teratomas in vivo when injected into SCID mice (Fig.1B). The
karyotype of the RbiPSC line was determined with Giemsa-banding,the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Fig. 1.Characterisation of RbiPSCs lineA)Above:Morphologyof generated RbiPSCs (4×) and representative immunoﬂuorescentmicrographs of iPSCs positive for stemcellsmarkers OCT4,
SOX2 and SSEA4 (in green), Nucleus is labelledwith DAPI (in blue). Alkaline phosphatase (AP) activitywas detectedwith live staining. Below: Spontaneously formedEBs (Day 5) and their
further differentiation (Day 14). Immunostainings for endodermal (GATA4), mesodermal (α-SMA, SMOOTHMUSCLE ACTIN) and ectodermal (TUBB3, βIII-TUBULIN) germ layer markers
(in green). Nucleus is labelled with DAPI (in blue). B) In vivo differentiation potential by Teratoma assay: Hematoxylin-eosin staining revealed endoderm (1 respiratory ciliated
epithelium), mesoderm (skeletal muscle) and ectoderm (3 keratinized epithelium, 4 sebaceous, 5 stratum corneum, 6 keratohialin granules) tissues. C) Karyogram of RbiPSC is
showing normal 44 chromosomes (XX) (Magniﬁcation: 120×; resolution: 300 dpi).
17Z. Táncos et al. / Stem Cell Research 21 (2017) 16–18proving normal diploid 44, XX karyotype, without any detectable ab-
normalities (Fig. 1C).
Materials and methods
Experimental procedures
The chemicals were purchased from Sigma-Aldrich (St Louis, MO,
USA) and all the culture reagents from Thermo Fisher Scientiﬁc (Wal-
tham, MA, USA), unless otherwise speciﬁed.
Cell culture
All cells were cultured at 38 °C in humidiﬁed atmosphere containing
5% CO2. The embryonic day 12 RbEF cells were cultured in Dulbecco's
modiﬁed Eagle medium (DMEM) supplemented with 10% FBS and
40 ng/ml bFGF. The ﬁbroblast cells were passaged by 0.05% trypsin-
EDTA and seeded in 1 × 105 cells/cm2 density 1 day before transduction.
The RbiPSCs were cultured in iPSM (DMEM/Ham's F-12 supplemented
with 20% knock-out serum replacement (KSR), 2 mM GlutaMax, 1%
nonessential amino acids, 0.1 mM β-mercaptoethanol, 4 ng/ml human
bFGF and 103 units/ml ESGRO LIF (murine leukemia inhibitory factor;
Millipore) supplemented with 4 ng/ml bFGF, changed daily and pas-
saged by 0.05% trypsin- EDTA every 3–4 days.
Reprogramming
For transduction 3 × 104 RbEFs were seeded into a well of a 24-well
plate on the day of transduction. 6 h later the virus-containing superna-
tant was diluted in 1 ml iPSM medium supplemented with polybrene
(ﬁnal concentration: 8 μg/ml). The MOI (Multiplicity of Infection) was
between 1 and 3. Two days post- transduction the RbEF cells weretreated with 0.05% trypsin-EDTA and plated on mitomycin C-treated
MEFs in iPSM medium (6000 cells/cm2). The medium was refreshed
daily. The appearing ES-like colonies were manually picked (Day 25–
30) onto MEF and cultured as iPSCs thereafter.
Immunocytochemistry and AP staining
Cellswere ﬁxed in 4% paraformaldehyde (PFA) for 30min at RT, then
permeabilized in PBS containing 0.1% Triton X-100 (Sigma) for 5 min
and blocked by 3% bovine serum albumin for 1 h at RT. The cells were
incubated with primary antibodies (overnight at 4 °C) and visualized
with secondary antibodies. For nuclei counterstaining 0.2 μg/ml DAPI
(20 min, RT) was used. The antibodies and applied dilutions are listed
in (Table 1). For detecting alkaline phosphatase (AP) activity, RbiPSCs
were stained using AP live stain kit (Life Technologies) according to
the manufacturer's protocol. The cells were observed under ﬂuorescent
microscope equipped with 3D imaging module, (Axio Imager system
with ApoTome; Carl Zeiss) controlled by AxioVision 4.8.1 microscope
software (Carl Zeiss).
Karyotyping
Cells were treated with KaryoMAX® Colcemid™ Solution (Thermo
Fisher Scientiﬁc) and processed with standard methods. Standard
Giemsa-banded karyotype was performed and minimum of 20 meta-
phases were analyzed.
In vitro differentiation
The RbiPSCs were treated with 0.05% trypsin-EDTA, resuspended in
differentiation medium (DMEM/Ham's F-12, 20% KSR, 2 mM GlutaMax,
1% nonessential amino acids, and 0.1 mM β-mercaptoethanol
Table 1
Antibodies used for immunocytochemistry.
Antibody Dilution Company (Cat #)
Pluripotency mouse anti-SOX2 1:200 Santa Cruz Biotechnologies; (sc-365823)
mouse anti-OCT4 1:50 Santa Cruz Biotechnologies; (sc-5279)
mouse anti-SSEA4 1:100 Hybridoma Bank; (MC-813-70)
In vitro differentiation rabbit anti-β-III-TUBULIN 1:2000 Covance (PRB-435P)
rabbit anti-SMOOTH MUSCLE ACTIN 1:100 Abcam (ab5694)
mouse anti-GATA4 1:50 Santa Cruz Biotechnologies; (sc-25310)
Secondary antibodies Alexa Fluor 488 donkey anti-mouse IgG 1:2000 Thermo Fisher Scientiﬁc (A-21202)
Alexa Fluor 488 donkey anti-rabbit IgG 1:2000 Thermo Fisher Scientiﬁc (A-21206)
18 Z. Táncos et al. / Stem Cell Research 21 (2017) 16–18supplemented freshly with 4 ng/ml bFGF, and 50 ng/ml activin A (R & D
systems), and cultured in low cell binding Petri-dishes (Nunc). After
5 days the Embryoid Bodies (EBs) were plated on 0.1% gelatin covered
cover slips in differentiation medium and ﬁxed with 4% PFA on Day 14
of differentiation.In vivo differentiation
For teratoma assay 1–2 × 106 RbiPSCs were injected under the kid-
ney capsule of ﬁve- to eight-week-old SCID mice. After four to eight
weeks teratomas were dissected and ﬁxed in 4% PFA (overnight at 4
°C), then embedded in parafﬁn with standard methods. Parafﬁn wax
sections were stained with hematoxylin and eosin. Tissue sections
were analyzed histologically.Acknowledgement
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